Apparatus for Tissue Cauterization
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 11/382,652, filed May 10, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,058,478 | Laparoscopic Radiofrequency Surgical Device In force · High confidence | Aesculap AG | In force | High confidence | ||
| US 7,942,874 | Apparatus for Tissue Cauterization In force · Medium confidence | Aesculap AG | In force | Medium confidence | ||
| US 8,574,229 | Surgical Tool In force · High confidence | Aesculap AG | In force | High confidence | ||
| US 9,918,778 | Laparoscopic Radiofrequency Surgical Device In force · High confidence | Aesculap AG | In force | High confidence | ||
| US 8,888,770 | Apparatus for Tissue Cauterization Term ended Term ended Jun 2, 2026 · Medium confidence | Aesculap AG | Term ended | Term ended Jun 2, 2026 | Medium confidence |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Aesculap AG.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.